Gilead Sciences, Inc.
Sector
Industries
Location
Market Cap
USD 142.41 B
Share Price
USD 114.77
Avg Daily Volume
7,184,956
Change (1 day)
Change (1 year)
Change (YTD)
Eli Lilly and Company
USD 711.68
LLY
AbbVie Inc.
USD 210.60
ABBV
Roche Holding AG
USD 340.96
RO.SW
Novartis AG
USD 127.06
NOVN.SW
Novo Nordisk A/S
USD 56.99
NOVO-B.CO
AstraZeneca PLC
USD 150.15
AZN.L
Merck & Co., Inc.
USD 87.37
MRK
Thermo Fisher Scientific Inc.
USD 499.99
TMO
Amgen Inc.
USD 293.72
AMGN
Pfizer Inc.
USD 25.88
PFE
Sanofi
USD 102.38
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 395.12
VRTX
Bristol-Myers Squibb Company
USD 47.92
BMY
Chugai Pharmaceutical Co., Ltd.
USD 42.64
4519.T
Regeneron Pharmaceuticals, Inc.
USD 589.48
REGN
Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
---|
Eli Lilly and Company
USD 711.68
LLY
AbbVie Inc.
USD 210.60
ABBV
Roche Holding AG
USD 340.96
RO.SW
Novartis AG
USD 127.06
NOVN.SW
Novo Nordisk A/S
USD 56.99
NOVO-B.CO
AstraZeneca PLC
USD 150.15
AZN.L
Merck & Co., Inc.
USD 87.37
MRK
Thermo Fisher Scientific Inc.
USD 499.99
TMO
Amgen Inc.
USD 293.72
AMGN
Pfizer Inc.
USD 25.88
PFE
Sanofi
USD 102.38
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 395.12
VRTX
Bristol-Myers Squibb Company
USD 47.92
BMY
Chugai Pharmaceutical Co., Ltd.
USD 42.64
4519.T
Regeneron Pharmaceuticals, Inc.
USD 589.48
REGN